TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹461 Cr | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹461 Cr |
| Mar2025 | ₹-253 Cr |
| Mar2024 | ₹319 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹-175 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹461 Cr | Positive | |
| Mar2025 | ₹-253 Cr | Negative | |
| Mar2024 | ₹319 Cr | 955.47 | |
| Mar2023 | ₹30 Cr | Positive | |
| Mar2022 | ₹-175 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹181,488.8 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| MANKIND PHARMA | ₹106,446.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.9% |
2.1% |
30.7% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses